永利3044(中国集团)有限公司官网

Recombinant Human CD160 (His-Avi Tag)
分享
收藏
产品详情
FAQ
产品文档
已发表文献
推荐应用
产品介绍

CD160 (also Natural killer cell receptor BY55) is a 27-30 kDa member of the Ig superfamily. In human, it is expressed principally on nonmyeloid hematopoietic cells. These include CD56DIMCD16+ cytolytic NK cells, CD8+CD28- T cells, CD8+CD101+ IELs, NKT cells, gamma δ TCR T cells, activated CD4+ T cells, and vascular endothelial cells. CD160 was initially identified as a GPI‑linked glycoprotein. It is synthesized as a preproprotein that is 181 amino acids (aa) in length. The precursor contains a 26 aa signal sequence, a 133 aa mature molecule that shows one 96 aa V-type Ig-like domain (aa 27-122), and a 22 aa prosegment that is cleaved to generate a GPI-linkage at Ser159. GPI-linked CD160 is known to be cleaved by phospholipases and these generate an 80 kDa (presumably trimeric) band in SDS-PAGE. Alternative splice forms for CD160 are reported to exist on activated NK cells. The principal variant is an extended type I transmembrane (TM) protein that shows a 55 aa substitution for the C-terminal two amino acids. It contains a 23 aa TM segment (aa 160-182) and a 52 aa cytoplasmic region. Two other variants show deletions of the Ig-like domain in both the GPI-linked and TM form .

产品性质
产品特色

高纯度、高活性、低内毒素、高批间一致性

应用案例

产品数据
 

image.png
image.png

存储条件

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。

COA
已发表文献
推荐应用

【应用方向】BCMA/TNFRSF17:多发性骨髓瘤免疫治疗的核心靶点蛋白

161

2026-08-31

【应用方向】CD20:B细胞恶性肿瘤免疫治疗的核心靶点蛋白

167

2026-08-31

【应用方向】CD19:血液肿瘤免疫治疗的核心靶点蛋白

190

2026-08-31

【文献解读】Science 重磅成果:西湖大学团队攻克共价蛋白药物核心瓶颈,建立通用高通量速效蛋白筛选平台

358

2026-06-25

【技术讲解】信号通路系列 | Wnt/β-catenin信号通路:细胞的“信号转换器”与“命运规划师”

716

2026-04-29

【文献解读】EGFR信号通路的耐药新视角:当EGFR-TKI遇上免疫压力,肿瘤如何“金蝉脱壳”?

516

2026-04-29

【应用方向】免疫检查点核心家族:B7-CD28超家族蛋白

1106

2026-04-21

【应用方向】TIM-3:下一代肿瘤免疫检查点治疗的核心靶点

817

2026-04-21

【应用方向】SIRP家族分子详解与产品选择指南

693

2026-04-21

【应用方向】OX40-OX40L共刺激轴的T细胞存活调控

759

2026-04-21

【应用方向】LILRB家族:髓系细胞免疫检查点的研究前沿与产品解决方案

1001

2026-04-21

【应用方向】LAG-3(CD223):T细胞耗竭调控网络的核心节点

921

2026-04-21

【应用方向】B7-H3(CD276):双重功能免疫检查点的分子特征与科研应用

1508

2026-04-20

【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量

14678

2026-03-02

【技术讲解】细胞因子科学选型--常见问题解答

11288

2026-09-21

联系我们
购物车
客服
转染试用
XML 地图